Final draft press release Q!'FY25 Morepen
PRESS RELEASE
Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India
PRESS RELEASE
Morepen Laboratories Limited’ Q3 FY24 EBITDA Surges By 151 Per Cent, Net Profit Records A Remarkable 256 Per Growth
PRESS RELEASE
Morepen - The Future of Home Diagnostics and OTC Health Products
PRESS RELEASE
Mr. Sushil Suri, Chairman & MD of Morepen Laboratories Ltd. honored to be the chief guest of the Annual Graduation & Convocation Ceremony of Chandigarh University.
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr Morepen launches advanced Muscle Food to fuel performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr Morepen launches advanced muscle food
PRESS RELEASE
Dr. Morepen launches advanced Pre-workout Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Morepen Labs introduces advanced muscle food
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Dr. Morepen launches advanced muscle food
PRESS RELEASE
Dr. Morepen launches advanced Muscle Food to fuel your performance
PRESS RELEASE
Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine (Allegra)
PRESS RELEASE
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen Laboratories receives USFDA approval for Fexofinadin
PRESS RELEASE
Morepen gets USFDA nod to market generic anti-allergy drug
PRESS RELEASE
Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen gets USFDA nod for anti-allergy drug
PRESS RELEASE
Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine
PRESS RELEASE
Noticias farmacéuticas: Últimas noticias farmacéuticas, noticias y actualizaciones farmacéuticas indias
PRESS RELEASE
Actualités pharmaceutiques : dernières actualités pharmaceutiques, actualités pharmaceutiques indiennes et mises à jour
PRESS RELEASE
Morepen Labs’ exports to get ‘major boost’ with FDA nod for Allegra
PRESS RELEASE
Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen gets USFDA nod for Fexofinadine (Allegra)
PRESS RELEASE
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
PRESS RELEASE
Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22
PRESS RELEASE
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
PRESS RELEASE
This news turns out to be a lucky charm for Morepen Laboratories; read to find out more!
PRESS RELEASE
Morepen gets USFDA nod to market generic anti-allergy drug
PRESS RELEASE
Morepen bags US FDA approval for allergy drug Allegra
PRESS RELEASE
Morepen gets USFDA nod to market generic anti-allergy drug
PRESS RELEASE
Morepen gets USFDA nod to market generic anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen Laboratories receives USFDA approval
PRESS RELEASE
Morepen Labs has seen 36% growth in medical devices in Q2, Dr Morepen could be an IPO candidate: Sushil Suri
PRESS RELEASE
Morepen Laboratories gets USFDA nod for Fexofinadine
PRESS RELEASE
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
PRESS RELEASE
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
PRESS RELEASE
Morepen Laboratories gets USFDA nod to market generic anti-allergy drug
PRESS RELEASE
Morepen gets USFDA nod to market generic anti-allergy drug
PRESS RELEASE
Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Laboratories Ltd consolidated Q2FY22 PAT at Rs. 37.36 crore
PRESS RELEASE
Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore
PRESS RELEASE
Morepen records 70 percent increase in Profit before tax in Q2 Consolidated Revenue grows by 17%
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit rises 38% at Rs. 37.36 crore
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 crore
PRESS RELEASE
Morepen Laboratories Sept-Quarter Consol Net Profit Rises
PRESS RELEASE
Morepen Laboratories Sept-Quarter Consol Net Profit Rises
PRESS RELEASE
: Morepen Labs Q2 Results: Net Profit Up 38%
PRESS RELEASE
Morepen Labs Q2 Results: Net Profit Up 38%
PRESS RELEASE
Morepen Laboratories Q2
PRESS RELEASE
Morepen Laboratories reports rise in Q2 net profit
PRESS RELEASE
Morepen Laboratories consolidated net profit rises 37.50% in the September 2021 quarter
PRESS RELEASE
Morepen records 70 percent increase in Profit before tax in Q2 with consolidated revenue growth of 17%
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Morepen records 70% increase in profit before tax in Q2
PRESS RELEASE
Morepen Labs Q2 net profit up 38 %
PRESS RELEASE
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
PRESS RELEASE
Boman Irani stars in Dr Morepen's latest ad
PRESS RELEASE
Morepen ropes in Boman Irani for their Medical Devices Campaign
PRESS RELEASE
Morepen Ropes In Boman Irani For Their Medical Devices Campaign
PRESS RELEASE
Morepen shareholders approve new unit to house medical device biz
PRESS RELEASE
Morepen shareholders approve new unit to house medical device biz
PRESS RELEASE
Morepen shareholders approve new unit to house medical device business
PRESS RELEASE
Morepen shareholders approve new unit to house medical device business
PRESS RELEASE
Morepen Lab carves out its Medical Devices into a Subsidiary
PRESS RELEASE
Morepen Lab carves out its Medical Devices into a Subsidiary
PRESS RELEASE
Morepen Labs Forms New Subsidiary For Medical Devices
PRESS RELEASE
Morepen carves out its Medical Devices into a Subsidiary
PRESS RELEASE
Morepen Laboratories Q4 net rises over two-fold to Rs 27 cr
PRESS RELEASE
Morepen Laboratories Q4 net profit rises over two-fold to Rs 27 cr
PRESS RELEASE
Transcript of Conference Call Q4-FY21
PRESS RELEASE
Morepen Labs Reports yet another growth-filled quarter
PRESS RELEASE
Scrutinizers Report for the AGM - 18.09.2015
PRESS RELEASE
PRESS RELEASE - May 2013 - Morepen Financial Results
PRESS RELEASE